Scientists who work in mycology — the study of fungi — say there is precious little money available to study Candida auris, according to an article on the STAT News website.
Candida auris is making news for its ability to resist multiple antifungal drugs and settle into hospital rooms so persistently it can take renovations to get rid of it.
The head of mycotic diseases at the Centers for Disease Control and Prevention (CDC) acknowledged his field hasn’t attracted the same kind of research dollars as other pathogens.
A high proportion of people who have been diagnosed with C. auris have died — the CDC estimates it’s between 30 percent and 60 percent.
The Role of Positive Distraction in Pediatric Design
Healthcare Waste is Fueling America's Debt
Prairie Lakes Healthcare System to Rebrand Following Sanford Health Merger
How Digital Technologies Are Reshaping Performance in Healthcare Facilities
The Role of Plumbing in Healthcare-Associated Infections